Hepatitis E in developed countries: current status and future perspectives. Dalton HR, Kamar N, Izopet J.Future Microbiol. 2014;9(12):1361-72. doi: 10.2217/fmb.14.89. Review.
Hepatitis E virus infections in blood donors, France.Gallian P, Lhomme S, Piquet Y, Sauné K, Abravanel F, Assal A, Tiberghien P, Izopet J.Emerg Infect Dis. 2014 Nov;20(11):1914-7. doi: 10.3201/eid2011.140516.
[Hepatitis E virus: Blood transfusion implications].Gallian P, Piquet Y, Assal A, Djoudi R, Chiaroni J, Izopet J, Tiberghien P.Transfus Clin Biol. 2014 Nov;21(4-5):173-7. doi: 10.1016/j.tracli.2014.07.007. Epub 2014 Sep 27. Review. French.
Hepatitis A virus subgenotyping based on RT-qPCR assays. Coudray-Meunier C, Fraisse A, Mokhtari C, Martin-Latil S, Roque-Afonso AM, Perelle S.BMC Microbiol. 2014 Nov 25;14:296. doi: 10.1186/s12866-014-0296-1.
Protracted fecal shedding of HEV during ribavirin therapy predicts treatment relapse. Abravanel F, Lhomme S, Rostaing L, Kamar N, Izopet J. Clin Infect Dis. 2015 Jan 1;60(1):96-9. doi: 10.1093/cid/ciu742. Epub 2014 Sep 23
Hepatitis E virus: chronic infection, extra-hepatic manifestations, and treatment. Kamar N, Abravanel F, Lhomme S, Rostaing L, Izopet J. Clin Res Hepatol Gastroenterol. 2015 Feb;39(1):20-7. doi: 10.1016/j.clinre.2014.07.005. Epub 2014 Aug 21
Safety measures to prevent hepatitis E virus transmission by blood transfusion. Laperche S, Izopet J, Lefrère JJ. Transfusion. 2014 Aug;54(8):2134-5. doi: 10.1111/trf.12735.
Characterization of the polyproline region of the hepatitis E virus in immunocompromised patients.Lhomme S, Abravanel F, Dubois M, Sandres-Saune K, Mansuy JM, Rostaing L, Kamar N, Izopet J.J Virol. 2014 Oct;88(20):12017-25. doi: 10.1128/JVI.01625-14. Epub 2014 Aug 6.
Ribavirin for chronic hepatitis E virus infection. Kamar N, Mallet V, Izopet J. N Engl J Med. 2014 Jun 19;370(25):2447-8. doi: 10.1056/NEJMc1405191.
Hepatitis E infection in patients with severe acute alcoholic hepatitis. Haim-Boukobza S, Coilly A, Sebagh M, Bouamoud M, Antonini T, Roche B, Yordanova O, Savary J, Saliba F, Duclos-Vallee JC, Samuel D, Ichai P, Roque-Afonso AM. Liver Int. 2015 Mar;35(3):870-5. doi: 10.1111/liv.12610.
Severe acute hepatitis E in an HIV infected patient: Successful treatment with ribavirin. Robbins A, Lambert D, Ehrhard F, Brodard V, Hentzien M, Lebrun D, Nguyen Y, Tabary T, Peron JM, Izopet J, Bani-Sadr F. J Clin Virol. 2014 Aug;60(4):422-3. doi: 10.1016/j.jcv.2014.05.003. Epub 2014 May 13
Ribavirin for chronic hepatitis E virus infection in transplant recipients.Kamar N, Izopet J, Tripon S, Bismuth M, Hillaire S, Dumortier J, Radenne S, Coilly A, Garrigue V, D’Alteroche L, Buchler M, Couzi L, Lebray P, Dharancy S, Minello A, Hourmant M, Roque-Afonso AM, Abravanel F, Pol S, Rostaing L, Mallet V.N Engl J Med. 2014 Mar 20;370(12):1111-20. doi: 10.1056/NEJMoa1215246.
Does chronic hepatitis E virus infection exist in immunocompetent patients? Kamar N, Izopet J. Hepatology. 2014 Jul;60(1):427. doi: 10.1002/hep.26927. Epub 2014 May 27.
Prospective study of Hepatitis E Virus infection among pregnant women in France. Renou C, Gobert V, Locher C, Moumen A, Timbely O, Savary J, Roque-Afonso AM; Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux (ANGH). Virol J. 2014 Apr 9;11:68. doi: 10.1186/1743-422X-11-68
Hepatitis E: An emerging infection in high income countries. Arends JE, Ghisetti V, Irving W, Dalton HR, Izopet J, Hoepelman AI, Salmon D. J Clin Virol. 2014 Feb;59(2):81-8.
Should we screen blood products for hepatitis E virus RNA ? Féray C, Pawlotsky JM, Roque-Afonso AM, Samuel D, Dhumeaux D. Lancet. 2014 Jan 18;383(9913):218.
Biphasic hepatitis A with severe cholestasis and thrombocytopenic purpura in an HIV-1-infected male patient. Bani-Sadr F, Chakvetadze C, Galperine T, Lassel L, Bonnard P, Lependeven C, Roque-Afonso AM, Pialoux G. Med Mal Infect. 2014 Jan 13. pii: S0399-077X(13)00341-7.
Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Hauser L, Roque-Afonso AM, Beylouné A, Simonet M, Deau Fischer B, Burin des Roziers N, Mallet V, Tiberghien P, Bierling P. Blood. 2014 Jan 30;123(5):796-7.
Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve to chronic infections. Abravanel F, Lhomme S, Chapuy-Regaud S, Mansuy JM, Muscari F, Sallusto F, Rostaing L, Kamar N, Izopet J. J Infect Dis. 2014 Jan 16.
Influence of polyproline region and macro domain genetic heterogeneity on HEV persistence in immunocompromised patients. Lhomme S, Garrouste C, Kamar N, Saune K, Abravanel F, Mansuy JM, Dubois M, Rostaing L, Izopet J. J Infect Dis. 2014 Jan 15;209(2):300-3.
Hepatitis E virus infection. Kamar N, Dalton HR, Abravanel F, Izopet J. Clin Microbiol Rev. 2014 Jan;27(1):116-38.